51. |
|
|
52. |
|
|
53. |
|
|
54. |
|
|
55. |
- Gudbjörnsdottir, Soffia, 1962, et al.
(författare)
-
[The National Diabetes Registry 1996-2003. Quality assessment shows improved diabetic care]
- 2004
-
Ingår i: Lakartidningen. - 0023-7205. ; 101:47, s. 3790, 3793-7
-
Forskningsöversikt (refereegranskat)abstract
- The Swedish National Diabetes Register presents results during the period 1996-2003. Quality of care data from more than 75,000 diabetic patients (2003) treated at medical departments and primary health care centres are evaluated concerning national goals of HbA1c < 6.5% and BP < 140/85 mm Hg, the prevalence of lipid treatment, smoking etc. The national goals of HbA1c and BP were reached with increasing degree in cross-sectional analysis during the period, and were achieved by 33% and 71% at medical departments, and by 61% and 48% in primary health care in 2003. A similar tendency was also seen in longitudinal analysis of subgroups 1996-2003. The use of antihypertensive and lipid-lowering drugs was also considerably increased. This should imply a reduction of the risk for diabetic complications. As the national goals are still difficult to reach, individual goals should be set for the treatment.
|
|
56. |
|
|
57. |
|
|
58. |
|
|
59. |
- Henriksson, F, et al.
(författare)
-
Samhällsekonomiska studier av diabetes behövs. Ger underlag för beslutsfattande och för internationella jämförelser
- 1999
-
Ingår i: Läkartidningen. - 0023-7205. ; 96:37, s. 9-3915
-
Tidskriftsartikel (refereegranskat)abstract
- Cost-of-illness studies have shown diabetes to be associated with substantial direct and indirect costs, accounting for 5-6 percent of total health care expenditure. In a Swedish study, where total costs were divided into costs due to management of diabetes and costs due to complications, the total annual cost to the community was estimated to be SEK 5.7 billion in 1994, costs due to complications being the major item, accounting for over 75 per cent of the total. There have been few other Swedish studies of costs for diabetes or diabetes-related complications. The most widely studied category of complications is diabetes-related foot ulcers, with an estimated annual cost of SEK 1-2 billion. However, earlier studies were marred by shortcomings: costs estimated for the main diagnosis only, without breakdown into categories or distinction between type 1 and type 2 diabetes, sources of data other than official data-bases ignored, etc. Diabetes care in Sweden is of high quality, and substantial clinical, epidemiological and health economics research has been carried out. It is important that Sweden contributes to international research on health economics aspects of diabetes.
|
|
60. |
|
|